Capital
Backers
1 investorAmounts in EUR, converted at the ECB rate on the event date. Funding totals exclude debt, grants and state aid; rounds whose instrument is not yet established are still counted. Every figure links to its source.
Activity
1 event
- Launch03 Sep 2026EUR 61.0M
Northway Biotech has opened a 61 million Euro Innovative Cell Therapy and Personalized Medicine Center in Vilnius, which will create about 100 high-skilled jobs.
▸Source: Verslo žinios
“Mokslininko ir verslininko Vlado Algirdo Bumelio kontroliuojama „Northway Biotech“ įmonių grupė Vilniuje atidarė 61 mln. Eur vertės Inovatyvų ląstelių terapijos ir personalizuotos medicinos centrą.”
People
1 person
Vladas Algirdas Bumelis
Scientist and Entrepreneur
Questions
3 answers
- What does Northway Biotech do?
- Northway Biotech is a biotechnology company focused on innovative cell therapy and personalized medicine.
- Where is Northway Biotech headquartered?
- Northway Biotech is based in Lithuania.
- Who has invested in Northway Biotech?
- Investors in Northway Biotech include ILTE.
The newsletter
One issue a week. Tuesday at 06:00 CET.
Funding rounds, exits, hires, and launches from eight Nordic and Baltic countries. Read in under five minutes, with one editor’s judgement on every issue.
No ads · No algorithmic feed · Free